Lars Gullestad

1.8k total citations
14 papers, 330 citations indexed

About

Lars Gullestad is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Lars Gullestad has authored 14 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Nutrition and Dietetics. Recurrent topics in Lars Gullestad's work include Magnesium in Health and Disease (3 papers), Parathyroid Disorders and Treatments (2 papers) and Viral Infections and Immunology Research (2 papers). Lars Gullestad is often cited by papers focused on Magnesium in Health and Disease (3 papers), Parathyroid Disorders and Treatments (2 papers) and Viral Infections and Immunology Research (2 papers). Lars Gullestad collaborates with scholars based in Norway, United States and Germany. Lars Gullestad's co-authors include Pål Aukrust, Thor Ueland, Terje Espevik, Stig S. Frøland, Gail Yee, Randall H. Vagelos, Michael B. Fowler, P Aukrust, D Falch and L. Ø. Dolva and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Alcoholism Clinical and Experimental Research.

In The Last Decade

Lars Gullestad

12 papers receiving 320 citations

Peers

Lars Gullestad
Lars Gullestad
Citations per year, relative to Lars Gullestad Lars Gullestad (= 1×) peers Sumiyo Yamashita

Countries citing papers authored by Lars Gullestad

Since Specialization
Citations

This map shows the geographic impact of Lars Gullestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Gullestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Gullestad more than expected).

Fields of papers citing papers by Lars Gullestad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Gullestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Gullestad. The network helps show where Lars Gullestad may publish in the future.

Co-authorship network of co-authors of Lars Gullestad

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Gullestad. A scholar is included among the top collaborators of Lars Gullestad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Gullestad. Lars Gullestad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Söderström, Sylvia, Silvana Bucher Sandbakk, Lars Gullestad, et al.. (2024). Mind the intention-behavior gap: a qualitative study of post-myocardial infarction patients’ beliefs and experiences with long-term supervised and self-monitored physical exercise. BMC Sports Science Medicine and Rehabilitation. 16(1). 204–204.
2.
Ćhilton, Robert, Lars Gullestad, Silvio E. Inzucchi, et al.. (2016). Abstract 13520: Empagliflozin Reduces Markers of Arterial Stiffness, Vascular Resistance and Cardiac Workload in EMPA-REG OUTCOME. Circulation. 134(suppl_1). 9 indexed citations
3.
Cowie, Martín, Holger Woehrle, Olaf Oldenburg, et al.. (2015). Sleep-disordered Breathing in Heart Failure – Current State of the Art. Cardiac failure review. 1(1). 16–16. 2 indexed citations
4.
Cornu, Catherine, Ségolène Gaillard, François Gueyffier, et al.. (2013). Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 78(1). 24–32. 12 indexed citations
5.
Hognestad, Aina, Pål Aukrust, Ragnhild Wergeland, et al.. (2004). Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation. Clinical Cardiology. 27(4). 199–203. 37 indexed citations
6.
Gullestad, Lars, Halfdan Aass, Halfdan Ihlen, et al.. (2001). [Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin].. PubMed. 121(16). 1902–7. 5 indexed citations
7.
Gullestad, Lars & P Aukrust. (2001). The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets.. PubMed. 2(1). 8–13. 17 indexed citations
8.
Gullestad, Lars, Pål Aukrust, Thor Ueland, et al.. (1999). Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. Journal of the American College of Cardiology. 34(7). 2061–2067. 193 indexed citations
9.
Metz, Jonas A., Peter Preuß, Nobuyuki Komiyama, et al.. (1996). Discrimination between soft plaque and thrombus based on radiofrequency analysis of intravascular ultrasound. Journal of the American College of Cardiology. 27(2). 200–200. 4 indexed citations
10.
Gullestad, Lars, et al.. (1995). [Intermittent claudication and beta-blockaders. An unfortunate combination?].. PubMed. 115(6). 725–8.
11.
Gullestad, Lars, et al.. (1992). Oral versus intravenous magnesium supplementation in patients with magnesium deficiency.. PubMed. 10(1). 11–6. 7 indexed citations
12.
Gullestad, Lars, et al.. (1992). Oral Magnesium Supplementation Improves Metabolic Variables and Muscle Strength in Alcoholics. Alcoholism Clinical and Experimental Research. 16(5). 986–990. 35 indexed citations
13.
Gullestad, Lars, et al.. (1989). Interaction of Naloxone and Timolol on Maximal Exercise Capacity and the Subjective Perception of Fatigue. International Journal of Sports Medicine. 10(4). 259–263. 7 indexed citations
14.
Gullestad, Lars, et al.. (1986). [Magnesium and cardiovascular diseases].. PubMed. 106(7). 554–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026